--- title: "3 'Strong Buy' Dividend Aristocrat Stocks with 100%+ Payout Ratios, 5/14/26" type: "News" locale: "en" url: "https://longbridge.com/en/news/286462897.md" description: "The article highlights three 'Strong Buy' Dividend Aristocrat stocks: AbbVie (ABBV), Abbott Laboratories (ABT), and NextEra Energy (NEE), all with payout ratios exceeding 100%. AbbVie has a payout ratio of 132.10% and a dividend yield of 3.23%, Abbott's is 140.52% with a yield of 2.89%, and NextEra's is 121.93% with a yield of 2.45%. Each stock is rated as a Strong Buy by analysts, indicating significant upside potential for investors seeking reliable dividend income." datetime: "2026-05-14T20:15:24.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286462897.md) - [en](https://longbridge.com/en/news/286462897.md) - [zh-HK](https://longbridge.com/zh-HK/news/286462897.md) --- # 3 'Strong Buy' Dividend Aristocrat Stocks with 100%+ Payout Ratios, 5/14/26 The article uses TipRanks' Dividend Aristocrat tool to identify AbbVie (ABBV), Abbott Laboratories (ABT), and NextEra Energy (NEE) as three dividend aristocrat stocks with a Strong Buy rating on Wall Street and more than 100% payout ratio. ### Claim 55% Off TipRanks - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Dividend aristocrats are members of the S&P 500 that have raised their dividends every year for at least 25 consecutive years. For income-oriented investors, that long-term track record is attractive because it supports a steady stream of cash payouts while still offering participation in the market's growth. ## **Why These 3 Dividend Aristocrats Are Top Picks** According to Wall Street analysts, the three stocks listed below are worth buying. They all have a payout ratio above 100%, meaning that each company recently distributed more than it gained in net earnings to shareholders as dividends. Furthermore, each company currently has a Buy rating based on consensus from top analysts or broader Wall Street agreement, with significant upside potential. Be sure to click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio. Here are today's top dividend aristocrat stock picks from TipRanks. 1. **AbbVie** (ABBV) — This American drugmaker is the brain behind Humira, the medication used to treat several inflammatory and autoimmune diseases. The Illinois-based company currently has **a** dividend payout ratio of 132.10%. ABBV paid $1.73 per share in its last dividend issuance, with a dividend yield of 3.23%. Its shares currently boast a Strong Buy consensus rating from 20 analysts. This comes with an average price target of $254.17 that suggests approximately 21% upside. 2. **Abbott Laboratories** (ABT) — This long-established American healthcare company manufactures and sells pharmaceutical and diagnostic products. It also produces medical devices and nutritional items. The Illinois-based company currently has a dividend payout ratio of 140.52%. Abbott paid 49 cents per share in its last dividend issuance, with a dividend yield of 2.89%. Its shares carry a Strong Buy consensus rating from 20 Wall Street analysts. This comes with an average price target of $120.24 that implies roughly 42% upside from current trading levels. 3. **NextEra Energy** (NEE) — This company positions itself as the world's largest producer of wind and solar energy. NextEra also generates electricity from other sources such as nuclear, coal, and natural gas. The Florida-based company currently has a dividend payout ratio of 121.93%. NextEra paid 62 cents per share in its last dividend issuance, with a dividend yield of 2.45%. Its shares currently boast a Strong Buy consensus rating from 13 Wall Street analysts. This is based on an average price target of $101.42 that indicates 6% upside. ## **More on Dividend Aristocrats** Some observers also treat recent spin-offs as dividend aristocrats if their parent companies meet the required track record, effectively granting the offshoot the parent's dividend history. ## **Interested in More Dividend Aristocrat Stocks?** To find more stocks like these, take a look at TipRanks' Dividend Aristocrats tool. The page provides an exhaustive list of all dividend aristocrats, including their most recent dividend yields, previous dividend amounts, payout ratios, and other details. ### Related Stocks - [ABT.US](https://longbridge.com/en/quote/ABT.US.md) - [NEE.US](https://longbridge.com/en/quote/NEE.US.md) - [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md) - [NEP.US](https://longbridge.com/en/quote/NEP.US.md) - [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md) - [NEE-N.US](https://longbridge.com/en/quote/NEE-N.US.md) - [NEE-W.US](https://longbridge.com/en/quote/NEE-W.US.md) - [NEE-R.US](https://longbridge.com/en/quote/NEE-R.US.md) - [NEE-T.US](https://longbridge.com/en/quote/NEE-T.US.md) - [NEE-U.US](https://longbridge.com/en/quote/NEE-U.US.md) - [NEE-S.US](https://longbridge.com/en/quote/NEE-S.US.md) - [NEE-V.US](https://longbridge.com/en/quote/NEE-V.US.md) ## Related News & Research - [AbbVie Delivers Strong Q1 Earnings Beyond Humira. This Dividend King Still Shines.](https://longbridge.com/en/news/285600926.md) - [NextEra Energy (NYSE:NEE) Sees Strong Trading Volume - Should You Buy?](https://longbridge.com/en/news/286809881.md) - [Atria Investments Inc Purchases 11,296 Shares of NextEra Energy, Inc. $NEE](https://longbridge.com/en/news/286523535.md) - [AbbVie Touts Record Sales and Pipeline Momentum at Annual Meeting](https://longbridge.com/en/news/285815191.md) - [NextEra slides 5% on Dominion megadeal but will shore up credit profile](https://longbridge.com/en/news/286814468.md)